HER2-Positive Breast Cancer: Who Gets Targeted Therapy, and Why?

When you are diagnosed with breast cancer, the pathology report comes back with a row of unfamiliar markers. If the line for 'HER2' is marked positive (+), your doctor will often bring up targeted therapy. The first time you hear it, it is easy to wonder how it differs from ordinary chemotherapy, and whether you really need it on top of everything else.

HER2 is a type of protein on the surface of cells. Breast cancers that make far too much of it are called HER2-positive, and they account for roughly one in five breast cancers. Because these cells tend to grow relatively quickly, this type was once considered difficult to treat. That changed considerably once drugs that target HER2 specifically became available.

A targeted drug does exactly what the name suggests: it latches onto a specific target on the cancer cell, here the HER2 protein, and blocks the signal telling it to grow. Trastuzumab (brand name Herceptin) has been used for a long time, and these days it is often combined with pertuzumab, or given as forms that bind a drug and a chemotherapy agent into a single molecule (such as T-DM1 or trastuzumab deruxtecan). Unlike standard chemotherapy, which hits cells broadly, targeting aims to preserve effectiveness while easing some of the burden.

So who is it for? The basic requirement is HER2 positivity confirmed on biopsy. Immunohistochemistry (IHC) scored 3+ qualifies; an ambiguous 2+ is settled with an added test such as FISH to check for gene amplification. Depending on the result, the drug may be combined with chemotherapy as adjuvant therapy before or after surgery, or, when there is metastasis, it may become the central pillar of treatment.

There are cautions, too. Some HER2 targeted drugs can affect the heart's pumping strength, so heart function is checked regularly with echocardiography before and during treatment. If your heart is already weak or you take other medications, it helps to tell your care team in advance. Rather than skipping or stopping doses on your own out of worry, it is safer to report any discomfort as it comes and adjust the dose and schedule together.

It is natural to feel a jolt of fear at the words 'HER2-positive.' But this is also the area where treatment options have grown the fastest. Exactly where your results fall, and which combination is recommended, is best confirmed step by step with your care team.

This article shares general medical information in plain language and does not replace individual diagnosis or treatment. Please discuss any specific decisions with your own care team.